Last reviewed · How we verify

ALK HDM AIT 6 DU — Competitive Intelligence Brief

ALK HDM AIT 6 DU (ALK HDM AIT 6 DU) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Allergen immunotherapy vaccine. Area: Immunology / Allergy.

phase 3 Allergen immunotherapy vaccine House dust mite allergens (Der p 1, Der p 2, Der f 1, Der f 2) Immunology / Allergy Small molecule Live · refreshed every 30 min

Target snapshot

ALK HDM AIT 6 DU (ALK HDM AIT 6 DU) — ALK-Abelló A/S. ALK HDM AIT 6 DU is an allergen immunotherapy (AIT) vaccine that desensitizes the immune system to house dust mite (HDM) allergens through repeated subcutaneous administration.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
ALK HDM AIT 6 DU TARGET ALK HDM AIT 6 DU ALK-Abelló A/S phase 3 Allergen immunotherapy vaccine House dust mite allergens (Der p 1, Der p 2, Der f 1, Der f 2)
ALK HDM AIT 12 DU ALK HDM AIT 12 DU ALK-Abelló A/S phase 3 Allergen immunotherapy vaccine House dust mite allergens (Der p 1, Der p 2, and other HDM proteins)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Allergen immunotherapy vaccine class)

  1. ALK-Abelló A/S · 2 drugs in this class
  2. Roxall Medicina España S.A · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). ALK HDM AIT 6 DU — Competitive Intelligence Brief. https://druglandscape.com/ci/alk-hdm-ait-6-du. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: